Exclusive news, data and analytics for financial market professionals
Learn more about
Refinitiv
Skip to main content
Reuters home
World
Business
Markets
Sustainability
Legal
Breakingviews
Technology
Investigations
More
My View
Register
Company
Novo Nordisk A/S
Follow
152 results
Business
category
FDA warns about safety risks of tailored weight-loss drugs
5:42 PM UTC
article with gallery
Future of Health
category
Obesity fighting success fuels Novo bet on gene-editing tech
May 24, 2023
Healthcare & Pharmaceuticals
category
Factbox: Weight-loss drugs: the next gold rush
May 23, 2023
Healthcare & Pharmaceuticals
category
Weight-loss drug pioneers aim to jump on Wegovy bandwagon
May 23, 2023
Markets
category
Wall Street ends mixed as investors await debt ceiling talks
May 23, 2023
article with video
Future of Health
category
Novo Nordisk, Pfizer weight-loss pills work as well as shots
May 22, 2023
Future of Health
category
Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic
May 22, 2023
Markets
category
European stocks muted as U.S. debt ceiling concerns linger
May 22, 2023
Business
category
Intercept tumbles on concerns over prospects of fatty liver disease drug
May 22, 2023
Business
category
US FDA panel votes against approval of Intercept fatty liver drug, cites safety issues
May 19, 2023
Future of Health
category
Obesity drug brings heart health benefit alongside weight loss, study says
May 19, 2023
Business
category
Catalent cuts forecast, delays results again as challenges mount
May 19, 2023
Business
category
Walmart lifts annual sales, profit view on resilient consumer spending
May 19, 2023
article with video
Business
category
US FDA staff flag 'serious' safety risks for Intercept's fatty-liver disease treatment
May 18, 2023
Business
category
Viking Therapeutics's NASH drug succeeds in mid-stage trial, shares jump
May 16, 2023
Healthcare & Pharmaceuticals
category
Exclusive: Wegovy, other weight loss drugs ‘no silver bullet’, says WHO amid obesity review
May 12, 2023
Healthcare & Pharmaceuticals
category
Insulin makers testify on Capitol Hill over prices
May 11, 2023
article with video
Breakingviews
category
Pharma’s obesity gold rush will have limits: podcast
May 11, 2023
Business
category
Potential weight-loss drug meets goals in mid-stage trial as race accelerates
May 10, 2023
Markets
category
European shares end higher, lifted by healthcare and bank stocks
May 8, 2023
1 to 20 of 152